Who Should Not Take TUDCA: Contraindications and Cautions
Tauroursodeoxycholic acid, or TUDCA, has become popular as a 'liver support' supplement in gyms and wellness circles. It is a bile acid with real pharmacological activity, and that is exactly why it is not suitable for everyone. Our editorial team sets out who should avoid it, who needs medical supervision and which assumptions are dangerous.
What TUDCA is and why contraindications matter
TUDCA is the taurine-conjugated form of ursodeoxycholic acid (UDCA), a bile acid present in small amounts in human bile and in larger amounts in bear bile, historically used in traditional Chinese medicine. Today it is made synthetically. In some countries, including Italy, TUDCA has been registered as a medicine for certain liver conditions.
In the UK, the closely related UDCA is a prescription medicine used for primary biliary cholangitis and some types of gallstones. TUDCA itself is mostly bought as an imported supplement, so it reaches users without the screening, warnings and monitoring that normally accompany a bile acid therapy.
Bile acids change bile flow, bile composition and signalling through receptors such as FXR and TGR5. These effects can be helpful in specific diseases, but in the wrong situation they may worsen symptoms or mask a condition that needs urgent treatment.
Understanding contraindications is therefore not a formality. Many of the people most interested in TUDCA, such as those with abnormal liver tests, are the very group in whom a proper diagnosis should come first.
Absolute contraindications: obstruction and acute inflammation
The clearest situation where bile acids like UDCA and TUDCA should not be used is complete obstruction of the bile ducts. If bile cannot drain into the intestine, increasing bile flow from the liver may raise pressure in the biliary tree rather than relieve it.
Acute inflammation of the gallbladder (cholecystitis) or bile ducts (cholangitis) is another contraindication listed in UDCA product information. These are medical emergencies that typically cause fever, pain in the right upper abdomen and sometimes jaundice; they require hospital assessment, not supplements.
Calcified gallstones, a non-functioning gallbladder and frequent episodes of biliary colic are also listed as reasons not to use UDCA for gallstone dissolution. Because TUDCA has a similar mechanism, the same caution reasonably applies.
| Situation | Why it matters | Status |
|---|---|---|
| Complete bile duct obstruction | Increased bile flow cannot drain | Avoid |
| Acute cholecystitis or cholangitis | Requires urgent medical treatment | Avoid |
| Calcified gallstones, non-functioning gallbladder | Bile acids ineffective, symptoms may worsen | Avoid |
| Known hypersensitivity to bile acids | Risk of allergic reaction | Avoid |
| Advanced cirrhosis | Specialist care needed | Only under supervision |
Groups needing medical supervision
Pregnancy and breastfeeding are important grey areas. UDCA is used by specialists for intrahepatic cholestasis of pregnancy, but that is a supervised medical treatment. Self-medicating with an imported TUDCA product during pregnancy is not appropriate, as safety data are limited and product quality uncertain.
People with inflammatory bowel disease, especially active Crohn's disease affecting the ileum, may absorb and recycle bile acids differently. Bile acids reaching the colon in larger amounts can cause diarrhoea, so symptoms may worsen.
Children and adolescents should not use TUDCA except under specialist care. Those with severe liver disease, such as decompensated cirrhosis, need hepatologist supervision, because bile acid therapy in advanced disease requires careful monitoring.
- Pregnant or breastfeeding women.
- People with Crohn's disease, ulcerative colitis or chronic diarrhoea.
- Patients with cirrhosis or primary sclerosing cholangitis.
- Anyone with unexplained abnormal liver blood tests.
- Children and teenagers.
Interactions with medicines
Bile acid binding resins such as colestyramine and colestipol, used for cholesterol or bile acid diarrhoea, can bind TUDCA in the gut and stop it being absorbed. Antacids containing aluminium can have a similar effect. UDCA labels advise separating doses by several hours.
UDCA can affect the absorption of ciclosporin, an immunosuppressant used after transplants, and may lower levels of some other drugs. Because transplant medicines have a narrow therapeutic window, anyone on such treatment must not add TUDCA without their transplant team's agreement.
Oestrogen-containing medicines and some cholesterol-lowering drugs can increase cholesterol saturation of bile and may work against the gallstone-dissolving effect. Again, these interactions are documented for UDCA and are reasonably expected to apply to TUDCA as well.
Always tell your GP or pharmacist if you take TUDCA. Many people do not mention supplements during consultations, which makes it harder to interpret blood tests and side effects.
The 'liver shield' misconception
A widespread belief in bodybuilding circles is that TUDCA allows oral anabolic steroids or other hepatotoxic substances to be used safely. This is a dangerous assumption. There are no controlled trials showing that TUDCA prevents liver injury from 17-alpha-alkylated steroids in humans.
Drug-induced liver injury can include cholestasis, peliosis hepatis and liver tumours. Bile acids may modestly improve some laboratory markers, which could make liver tests look better while underlying damage continues. That can delay diagnosis rather than prevent harm.
Similarly, TUDCA is not a treatment for alcohol-related liver disease or a reason to drink more. Reducing or stopping alcohol, weight management and treating viral hepatitis have far stronger evidence for protecting the liver.
If liver enzymes are raised, the NHS approach is to find the cause through history, blood tests and imaging. Adding a supplement before that process is complete can make the picture harder to read and postpone necessary treatment.
Editorial conclusions
TUDCA is a pharmacologically active bile acid, not an all-purpose liver tonic, and it is contraindicated in bile duct obstruction and acute biliary inflammation.
Pregnant women, people with IBD, cirrhosis or abnormal liver tests, and those on bile acid resins or transplant medicines need medical advice first.
It does not make hepatotoxic drugs safe, and it may hide the warning signs of liver injury.
Next, our editorial team recommends reading about ursodeoxycholic acid's effects on the liver and kidneys, how to interpret liver function tests and drug-induced liver injury in athletes.
References
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237–267.
- Vang S, Longley K, Steer CJ, Low WC. The unexpected uses of urso- and tauroursodeoxycholic acid in the treatment of non-liver diseases. Glob Adv Health Med. 2014;3(3):58–69.
- Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol. 2006;3(6):318–328.
- Crosignani A, Battezzati PM, Setchell KD, et al. Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis: a dose-response study. Dig Dis Sci. 1996;41(4):809–815.
- Robles-Diaz M, Gonzalez-Jimenez A, Medina-Caliz I, et al. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Aliment Pharmacol Ther. 2015;41(1):116–125.
- Chalasani NP, Maddur H, Russo MW, et al. ACG Clinical Guideline: diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2021;116(5):878–898.
